ELDON BIOLOGICALS A/S: Financial statements 2015
CVR: 26747007
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 6,061,341 and a net result of DKK 1,501,774 compared with DKK 1,067,436 the year before. That is an increase of 23.7% compared with the year before. Equity in the 2015 report amounted to DKK 318,935. The solvency ratio was 4.9%.
- Gross Profit
- DKK 6,061,341
- Profit/Loss
- DKK 1,501,774
- Equity
- DKK 318,935
- Total Assets
- DKK 6,455,327
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 6.1 mio. | 1.5 mio. | 319 t. | - |
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
Official annual report
How creditworthy is ELDON BIOLOGICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.